Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AESI, analyst, Anhui, ascertain, asymptomatic, BA, BMGF, breast, breastfeeding, carryforward, cavity, CCPA, Chair, circle, CMO, collapse, Colorado, concomitant, condensed, Connecticut, convalescent, CPRA, creation, crosstalk, CSL, cutoff, dataset, deceptive, deletion, Deposit, depository, dissemination, distal, dynamic, elaine, emphasized, energy, epigastric, EPO, ESPP, fatigue, fifteen, footnote, Fourteen, FTC, FTCA, GDPR, grey, heightening, heron, honor, household, humoral, hundred, hvivo, hyponatremia, ICFR, Impermissible, indeterminable, infant, injunction, Insight, invited, Israel, JCI, Kim, Korea, lactating, landscape, leave, Lee, left, lesser, Lim, Longcom, medrxiv, milk, minitablet, missed, mother, motion, mouth, nAb, nascent, negate, neglect, nirsevimab, nose, notification, NV, OCR, opponent, oropharyngeal, paragraph, Passive, postpone, postponed, preempted, proven, quarantining, reconsented, refundable, RSU, RSVpreF, Science, scrutinizing, sensitive, seroprotected, seroprotection, Silicon, spent, spot, SRC, SS, stockpiling, store, stored, stratified, suboptimal, substudy, SVB, takeover, telegraphed, tenant, tendency, thirst, thought, TLF, transient, Translational, Ukraine, underwent, unpaid, unreasonable, unsecured, upper, Utah, Valley, Virginia, waiting, watson, western, youngest, Zhifei
Removed:
Ablynx, accreted, accretion, Allergy, Alpharetta, Anorexia, antidilution, Ark, ASU, attest, Bavarian, BCC, billable, billing, BN, bore, borrowed, campaign, caption, ceased, consecutive, culturing, Datamonitor, declining, devastating, diphtheria, echerd, Emergent, entitling, envisaged, eradicating, evenly, evidenced, extinguishment, FASB, Fig, formatted, fraction, France, fringe, Georgia, Germany, Gilead, Gravidarum, horizontal, Houston, immunosorbent, indefinitely, inquiry, institute, intensified, investigated, Italy, leverage, LIBOR, loan, logistical, Lonza, loose, lymphoid, margaret, MEDI, Medicago, Merck, molecule, neuraminidase, Nordic, outpatient, owed, Oxford, Pittsburg, polio, polyclonal, presatovir, prioritizing, promissory, proof, ranged, rehydration, relying, repaid, repayable, repayment, requesting, retroactive, reversal, reversed, revert, roger, rolling, RPO, safely, school, Sean, separated, sequentially, Simplex, smallpox, Spain, split, subleased, subordinate, subordination, surfaced, suspended, tabulated, TEAE, therapy, top, Tucker, Unaudited, unbilled, underwriting, underwritten, verbatim, XBRL, zanamivir
Filing tables
Filing exhibits
Associated VXRT transcripts
VXRT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-239751 and 333-228910) and Form S-8 (Nos. 333-267984, 333-257245, 333-239727, 333-231013, 333-225475, 333-215141 and 333-143238) of Vaxart, Inc. of our report dated March 15, 2023, relating to the consolidated financial statements and the effectiveness of Vaxart, Inc.’s internal control over financial reporting, which appears in this Form 10-K.
/s/ WithumSmith+Brown, PC
San Francisco, California
March 15, 2023